Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- PAVM
- Price
- 10.27
- Stock movement down
- -0.18 (-1.72%)
- Company name
- PAVmed Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 9.46M
- Ent value
- 18.64M
- Price/Sales
- 326.26
- Price/Book
- 0.37
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 3.06
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 1458.42%
- 3 year return (CAGR)
- 13.48%
- 5 year return (CAGR)
- -22.63%
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PAVM does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 3.06 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 5.88 |
| EV to EBITDA | 11.59 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 326.26 |
| Price to Book | 0.37 |
| EV to Sales | 642.78 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 921.28K |
| EPS (TTM) | 0.14 |
| FCF per share (TTM) | -0.17 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 29.00K |
| Gross profit (TTM) | -194.00K |
| Operating income (TTM) | -20.19M |
| Net income (TTM) | 3.10M |
| EPS (TTM) | 0.14 |
| EPS (1y forward) | -17.10 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -668.97% |
| Operating margin (TTM) | -69627.59% |
| Profit margin (TTM) | 10672.41% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.10M |
| Net receivables | 3.00K |
| Total current assets | 4.19M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 2.21M |
| Total assets | 38.07M |
| Accounts payable | 342.00K |
| Short/Current long term debt | 9.28M |
| Total current liabilities | 10.46M |
| Total liabilities | 12.28M |
| Shareholder's equity | 25.79M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.56M |
| Capital expenditures (TTM) | 21.00K |
| Free cash flow (TTM) | -3.58M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 12.00% |
| Return on Assets | 8.13% |
| Return on Invested Capital | 9.31% |
| Cash Return on Invested Capital | -10.77% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 10.38 |
| Daily high | 10.67 |
| Daily low | 9.35 |
| Daily Volume | 69K |
| All-time high | 228.60 |
| 1y analyst estimate | 285.00 |
| Beta | 0.97 |
| EPS (TTM) | 0.14 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PAVM | S&P500 | |
| Current price drop from All-time high | -95.51% | -1.82% |
| Highest price drop | -99.90% | -56.47% |
| Date of highest drop | 31 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -86.87% | -10.84% |
| Avg time to new high | 585 days | 12 days |
| Max time to new high | 2337 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
9.46M
Marketcap category
Small-cap
Description
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York
Employees
39
Website
Investor relations
-
SEC filings
CEO
Lishan Aklog
Country
USA
City
New York
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page